A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 Alone and in Combination with Nivolumab in Adult and Adolescent Patients 12 Years and Older in Patients with Advanced Solid Tumors
This Study is
No Longer Enrolling
Child to Adult
I/II - A combination of phases: (1) Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants; and (2) Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Treatment
Lone Tree Medical Center
University of Colorado Hospital
Protocol Number: 17-2450
More information available at ClinicalTrials.gov: NCT03425279
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers